Nalini Jayaprakash

Sustained response and prevention of damage progression in patients with neonatal‐onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three‐ and five‐year outcomes

Cailin H. Sibley, N. Plass, Joseph Snow et al. · Arthritis & Rheumatism · 2012 · 210 citations · Full text

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Brigitte C. Widemann, Frank M. Balis, AeRang Kim et al. · Journal of Clinical Oncology · 2010 · 169 citations · Full text

Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

Brigitte C. Widemann, Wanda L. Salzer, R.J. Arceci et al. · Journal of Clinical Oncology · 2006 · 145 citations · Full text

A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors

Elizabeth Fox, Richard Aplenc, Rochelle Bagatell et al. · Journal of Clinical Oncology · 2010 · 105 citations · Full text

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

AeRang Kim, Brigitte C. Widemann, Mark Krailo et al. · Pediatric Blood & Cancer · 2015 · 88 citations · Full text